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OBJECTIVE—Previous animal studies suggest a functional re-
lationship between metabolism, type 2 diabetes, and the ampli-
tude of daily rhythms in white adipose tissue (WAT). However,
data interpretation is confounded by differences in genetic back-
ground and diet or limited sampling points. We have taken the
novel approach of analyzing serial human WAT biopsies across
a 24-h cycle in controlled laboratory conditions.
RESEARCH DESIGN AND METHODS—Lean (n = 8), over-
weight/obese (n = 11), or overweight/obese type 2 diabetic (n =
8) volunteers followed a strict sleep–wake and dietary regimen
for 1 week prior to the laboratory study. They were then main-
tained in controlled light–dark conditions in a semirecumbent
posture and fed hourly during wake periods. Subcutaneous WAT
biopsies were collected every 6 h over 24 h, and gene expression
was measured by quantitative PCR.
RESULTS—Lean individuals exhibited signiﬁcant (P , 0.05)
temporal changes of core clock (PER1, PER2, PER3, CRY2,
BMAL1,a n dDBP) and metabolic (REVERBa, RIP140,a n dPGC1a)
genes. The BMAL1 rhythm was in approximate antiphase with the
other clock genes. It is noteworthy that there was no signiﬁcant
effect (P . 0.05) of increased body weight or type 2 diabetes on
rhythmic gene expression.
CONCLUSIONS—The robust nature of these rhythms and their
relative phasing indicate that WAT now can be considered as
a peripheral tissue suitable for the study of in vivo human
rhythms. Comparison of data between subject groups clearly
indicates that obesity and type 2 diabetes are not related to the
amplitude of rhythmic WAT gene expression in humans maintained
under controlled conditions. Diabetes 60:1577–1581, 2011
C
ircadian clocks regulate daily changes in a wide
range of physiological and behavioral functions,
including the timing of sleep. Disruption of cir-
cadian biology or sleep has profound metabolic
consequences (1), which has led to the development of
a major research effort to understand the links between
these processes. By understanding the temporal regulation
of metabolic physiology, it is anticipated that common
behaviors and clinical interventions can be optimized to
reduce the impact of modern society on the incidence of
metabolic diseases, such as diabetes.
There are clear links between circadian clocks and
metabolism. In murine models, transgenic disruption of
key clock–related genes induces marked metabolic phe-
notypes (2–5). In humans, chronic desynchrony of internal
circadian time with the external environment (e.g., during
shift work) correlates with increased incidence of obesity,
type 2 diabetes, and cardiometabolic diseases (6). More-
over, consistent with the transgenic murine data, recent
work has linked polymorphisms of human circadian clock
genes with metabolic dysfunction (7–9).
The mammalian circadian timing system consists of
a “master” clock within the suprachiasmatic nuclei (SCN)
of the hypothalamus and a series of “peripheral” clocks
that are located in extra-SCN regions of the brain as well
as in almost all other tissues (10). The environmental light–
dark cycle synchronizes the circadian system by acting
through the SCN clock, which then maintains temporal
order of the peripheral clocks via multiple rhythmic out-
puts (10). These SCN-driven pathways include neuronal
(e.g., sympathetic tone), endocrine (e.g., melatonin and
cortisol secretion), and behavioral (e.g., feeding) activity.
Murine white adipose tissue (WAT), as with many other
tissues, contains endogenous circadian timing properties
(11,12), and ~10–20% of murine WAT transcriptome is es-
timated to exhibit a 24-h variation (13,14). It is noteworthy
that mice that are genetically susceptible to obesity and
type 2 diabetes (15) or fed a high-fat diet (16) exhibit re-
duced amplitude rhythms of gene expression in WAT,
leading to the hypothesis that the robustness of WAT clocks
is functionally associated with metabolic phenotype.
This hypothesis has not been rigorously tested in
humans. The principal reason for this important gap in our
knowledge stems from the difﬁculty in obtaining multiple
serial biopsies of tissue from human volunteers. To date,
the literature on rhythmic gene expression in human WAT
has primarily relied on either analysis of single-time–point
biopsies maintained in culture (17) or the relative ex-
pression of genes at a single time point (18,19). It is clear
that neither of these methods is ideal for the assessment of
24-h rhythms in vivo.
In this study, serial human biopsies across a 24-h cycle
were analyzed using a carefully controlled protocol de-
signed to minimize the effect of confounding factors on
rhythmic physiology. We studied three deﬁned groups
of human volunteers to investigate daily WAT rhythms;
lean individuals were compared with subjects who were
overweight/obese or overweight/obese with type 2 diabetes.
RESEARCH DESIGN AND METHODS
All aspects of the study were conducted in accordance with the Declaration of
Helsinki and received a favorable ethical opinion from the Surrey Research
Ethics Committee and the University of Surrey Ethics Committee.
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BRIEF REPORTVolunteers completed questionnaires to assess general health and ensure
normal sleep and diurnal preference. They then attended a prescreening
session at the University of Surrey, typically within 1 month of the laboratory
session and during the early afternoon. BMI and waist circumference were
measured, and fasting blood samples were provided for measurement of
plasma HbA1c, insulin and glucose concentrations, and homeostasis model
assessment of insulin resistance (HOMA-IR; calculated using HOMA calculator
version 2.2 software [Diabetes Trial Unit; University of Oxford, Oxford, U.K.]).
Twenty-seven male volunteers were recruited (8 lean, 11 overweight, and
8 overweight with type 2diabetes).Of the patients with type 2 diabetes, average
time since diagnosis was 6.9 6 2.3 years; three type 2 diabetic patients were
controlled by diet and exercise, and the other ﬁve patients were treated with
combinations of metformin, statins, ramipril, and lisinopril. One participant
within the lean group was a smoker and was required to refrain from smoking
for 1 week prior to the study. None of the participants had undertaken shift
work within 5 years of the study or crossed any time zones within 1 month of
the study.
For 1 week prior to the laboratory study, volunteers were required to
maintain prescribed daily feeding times and sleep activity (sleep 2230–0630 h),
which were monitored using wrist actigraphy (AWL; Cambridge Neuro-
technology, Cambridge, U.K.), sleep diaries, food diaries, and recorded mes-
sages on a laboratory time-stamped answer telephone. Participants also were
required to refrain from eating fatty or sugary foods and drinking alcohol or
caffeine throughout the week. For the ﬁnal 3 days of this baseline week, food
was provided by the research team to enable control of timed behavior to-
gether with both the quantity and quality of nutrient intake. During these
3 days, the daily caloric content of the supplied food was basal metabolic rate
times 1.5 with ~35% of energy from fat.
Laboratory study. All experimental procedures were carried out at the Surrey
Clinical Research Centre. Volunteers arrived in the afternoon of day 0 for
a night of adaptation. Throughout the 2-day study, they were required to
maintain a semirecumbent posture. They were required to remain awake with
lights on between 0630 and 2230 h (440–825 lux in direction of gaze) and
allowed to sleep with lights off between 2230 and 0630 h (0 lux). During the
waking period, participants were fed with hourly nutritional drinks (Fortisip;
Nutricia, Schiphol, the Netherlands) and were allowed to drink water ad
libitum. Daily energy intake was basal metabolic rate times 1.1, divided equally
over the waking hours.
Four subcutaneous WAT biopsies were taken under a local anesthetic
(lidocaine) from four different sites of the upper buttock region of each par-
ticipant at6-hourlyintervalsfor24h,beginningat1030honday1.Thesampling
order of the four biopsy sites was randomized between groups and subjects.
This WAT depot is known to exhibit metabolic activity (20).
Analysis of gene expression. WAT biopsies were washed with saline and
snap-frozen in liquid nitrogen before storage at 280°C. Total RNA was ex-
tracted using TRIzol, according to the manufacturer’s instructions. cDNA was
synthesized, and expression was measured for genes integral to the circadian
clock (PER1, PER2, PER3, CRY2, BMAL1,a n dDBP) and involved in meta-
bolic activity (REVERBa, RIP140,a n dPGC1a) by quantitative TaqMan real-
time PCR, as described previously (21) (Table 1). Standard curves (R
2 . 0.99)
were generated using human genomic DNA (Promega, Southampton, U.K.),
and expression of all genes was normalized to GAPDH, as in previous
studies of adipose clock gene expression (15,16).
Statistical analysis. Prescreen data were analyzed using one-way ANOVA
with Tukey’s post hoc test. Correlation analyses were conducted using linear
regression, and the gene expression time course from biopsies was performed
using one-way or two-way repeated-measures ANOVA (factors time and group)
with Tukey’s post hoc test.
RESULTS
Prescreen data are shown in Table 2. Despite efforts to
age-match the participants, there was a signiﬁcant (P ,
0.05) difference in age, with post hoc analysis revealing
a signiﬁcant difference only between the overweight and
type 2 diabetic groups. However, subsequent analysis us-
ing age as a covariant revealed that age, per se, did not
alter gene expression (data not shown). There were sig-
niﬁcant (P , 0.05) differences in BMI, waist circumfer-
ence, fasting plasma glucose and insulin concentrations,
HbA1c levels, and HOMA-IR, with highest values occur-
ring in participants with type 2 diabetes. There was no
signiﬁcant difference in plasma insulin, glucose, HbA1c,o r
HOMA-IR between the lean and overweight/obese groups,
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1578 DIABETES, VOL. 60, MAY 2011 diabetes.diabetesjournals.orgindicating that our overweight/obese participants were
insulin-sensitive.
In lean individuals, there was a signiﬁcant (P , 0.05)
effect of time on the expression of multiple genes involved
in circadian (PER1, PER2, PER3, CRY2, BMAL1,a n dDBP)
and metabolic functions (REVERBa, RIP140,a n dPGC1a)
(Fig. 1). Minimal expression of REVERBa and DBP oc-
curred around the middle to end of the afternoon. In
keeping with circadian gene expression in other tissues
(10), the phase of PER1, PER2, PER3,a n dCRY2 was
slightly delayed compared with REVERBa and DBP,w i t h
minimal expression occurring around the evening light–
dark transition. The BMAL1 rhythm was in approximate
antiphase to the other circadian genes, with maximal ex-
pression around the evening light–dark transition.
Analysis by two-way repeated-measures ANOVA of the
data from all of the experimental groups conﬁrmed a signif-
icant (P , 0.05) effect of time on gene expression (Fig. 2).
However, it is surprising that we did not observe a signiﬁ-
cant effect of experimental group on the expression of any
gene. The only gene to exhibit a signiﬁcant (P , 0.01) time 3
group interaction was BMAL1.T u k e y ’s post hoc analysis
revealed that BMAL1 expression 16.5 h after lights on
(equivalent to clock time 2300 h) was signiﬁcantly (P ,
0.05) lower in the overweight/obese participants than in the
lean or type 2 diabetic groups.
DISCUSSION
Consistent with a previous study (22), our data reveal
robust diurnal rhythmicity within human WAT in vivo. To
date, limited data have been published concerning clock
gene expression in this tissue. Because of difﬁculties in
acquiring human tissue, some studies have measured clock
gene expression in WAT collected at a single time point
(18,19), although it is clearly difﬁcult to infer rhythmical
changes from such a temporally limited dataset. An elegant
compromise has been to culture explants of tissue taken
at a single time point and then measure gene expression
in fragments of the biopsies over a 24-h time course (17).
Although such studies highlight endogenous WAT rhythms,
they do not reﬂect gene expression in vivo. Therefore, we
measured gene expression in human tissue explants har-
vested across a whole 24-h cycle to provide in vivo human
WAT rhythms.
Animal models suggest that obesity and type 2 diabetes
reduce rhythm amplitude in murine WAT because lean
C57BL/6J mice exhibit higher amplitude WAT rhythms
than obese/diabetic KK and KK-A
y mice (15). Other data
revealed reduced amplitude rhythms in mice that became
obese as a result of a high-fat diet (16). However, Ando
TABLE 2
Participant prelaboratory data
Variable
Lean
subjects
Overweight/
obese subjects
Type 2
diabetic
subjects
n 81 1 8
Age (years) 53.6 6 6.0 49.9 6 7.5 58.0 6 4.5*
BMI (kg/m
2) 23.2 6 1.4 30.2 6 2.3† 31.2 6 3.2†
Waist circumference
(cm) 88.9 6 6.5 105 6 4.3† 110.9 6 10.6†
Fasting glucose
(mmol/L) 4.2 6 0.7 4.8 6 0.7 6.7 6 1.3*†
Fasting insulin
(pmol/L) 28.1 6 16.8 39.2 6 17.4 93.6 6 78.7*†
HbA1c (mmol/L) 5.4 6 0.4 5.4 6 0.5 6.8 6 0.8*†
HOMA-IR 0.5 6 0.1 0.7 6 0.1 1.9 6 0.5*†
Data are means 6 SE. *P , 0.05 vs. overweight/obese group. †P ,
0.05 vs. lean group.
FIG. 1. Robust 24-h changes of gene expression in human WAT from lean individuals. Data are presented as means 6 SE of n =8 –11 values,
normalized to glyceraldehyde 3-phosphate dehydrogenase. There was a signiﬁcant effect of time (P < 0.05, one-way repeated-measures ANOVA)
on the expression of each gene. Horizontal bars represent wake (white) and sleep (black) periods during the laboratory study. Zeitgeber time
0 represents the time of lights on (equivalent to clock time 0630 h).
D.T. OTWAY AND ASSOCIATES
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grounds, which complicate interpretation of their data, and
it is possible that dietary intervention could directly reg-
ulate gene expression rather than obesity per se.
In contrast to the above studies, we observed minimal
differences between clock gene rhythms in human WAT.
Interpretation of the minor difference in BMAL1 expres-
sion is not clear. Although murine Bmal1 has been impli-
cated in the control of adipogenesis in vitro (23), juvenile
Bmal1
2/2 mice develop adipose depots comparably to
their wild-type littermates (24). Furthermore, the similarity
between gene expression proﬁles in lean individuals and
those who were overweight with type 2 diabetes suggests
that BMI is not the cause of the time 3 group interaction
for BMAL1 in the overweight, nondiabetic individuals.
The similarity of gene expression proﬁles between our
experimental groups may partly result from a lack of ex-
treme phenotypic differences. Although there was not a
large disparity in BMI between our groups, all participants
fell into the current clinical guidelines for lean/healthy,
obese, and type 2 diabetic individuals. Therefore, there
was no effect of obesity or type 2 diabetes, per se, on
human WAT rhythmicity. It remains possible that severely
obese individuals may exhibit reduced amplitude WAT
rhythmicity; however, interpretation of data from such
individuals is complicated by various confounding factors,
such as comorbidities associated with type 2 diabetes.
Another difference between our study and previous
work (25) is the high level of glycemic control in our
participants. We speciﬁcally aimed to investigate the re-
lationship between WAT rhythmicity, body weight, and
presence of type 2 diabetes. Therefore, we eliminated as
many additional factors as possible. Diurnal adipose gene
expression may be modulated by the level of glycemic
control and/or drugs taken by diabetic individuals. Alter-
natively, the association between metabolic state and WAT
rhythmicity might vary between adipose depots. However,
because of limitations of sampling and experimental group
size, we could not directly address these possibilities in the
current study.
The persistence of 24-h rhythms in WAT from patients
with type 2 diabetes now suggests that the link between
human circadian and metabolic physiology occurs outside
of WAT, at least in the earlier stages of the disease.
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